TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 102 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $251,000 | +128.2% | 522,725 | +439.1% | 0.00% | – |
Q4 2018 | $110,000 | -92.7% | 96,969 | -82.3% | 0.00% | -100.0% |
Q3 2018 | $1,512,000 | +42.1% | 547,814 | +83.9% | 0.00% | +100.0% |
Q2 2018 | $1,064,000 | +167.3% | 297,942 | +129.7% | 0.00% | 0.0% |
Q1 2018 | $398,000 | -97.7% | 129,689 | -95.2% | 0.00% | -95.8% |
Q4 2017 | $17,105,000 | +20.5% | 2,715,025 | +30.8% | 0.02% | +9.1% |
Q3 2017 | $14,197,000 | +236.9% | 2,075,558 | +251.2% | 0.02% | +175.0% |
Q2 2017 | $4,214,000 | +48.5% | 590,988 | +91.4% | 0.01% | +60.0% |
Q1 2017 | $2,838,000 | +347.6% | 308,807 | +96.2% | 0.01% | +400.0% |
Q4 2016 | $634,000 | +20.1% | 157,429 | +14.2% | 0.00% | 0.0% |
Q3 2016 | $528,000 | -44.8% | 137,870 | -38.0% | 0.00% | -50.0% |
Q2 2016 | $956,000 | -74.5% | 222,260 | -72.5% | 0.00% | -77.8% |
Q1 2016 | $3,744,000 | -52.4% | 808,720 | +3.2% | 0.01% | -47.1% |
Q4 2015 | $7,861,000 | +281.4% | 783,777 | +183.7% | 0.02% | +325.0% |
Q3 2015 | $2,061,000 | -88.5% | 276,281 | -26.9% | 0.00% | -88.2% |
Q2 2015 | $17,941,000 | +102.7% | 378,175 | +56.5% | 0.03% | +112.5% |
Q1 2015 | $8,853,000 | -59.8% | 241,623 | -56.5% | 0.02% | -66.0% |
Q4 2014 | $22,041,000 | +120.8% | 555,040 | +10.9% | 0.05% | +88.0% |
Q3 2014 | $9,983,000 | +19.8% | 500,401 | -19.0% | 0.02% | +8.7% |
Q2 2014 | $8,330,000 | -6.2% | 617,522 | -24.3% | 0.02% | -11.5% |
Q1 2014 | $8,879,000 | +143.9% | 815,316 | +202.8% | 0.03% | +136.4% |
Q4 2013 | $3,641,000 | – | 269,297 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 1,048,642 | $3,219,000 | 0.50% |
Virtus ETF Advisers LLC | 130,920 | $402,000 | 0.35% |
683 Capital Management, LLC | 600,000 | $1,842,000 | 0.16% |
Tekla Capital Management LLC | 859,322 | $2,638,000 | 0.10% |
DOW CHEMICAL CO /DE/ | 65,000 | $200,000 | 0.07% |
Alambic Investment Management, L.P. | 115,834 | $356,000 | 0.05% |
A.R.T. Advisors, LLC | 262,896 | $807,000 | 0.03% |
Candriam S.C.A. | 520,613 | $1,598,000 | 0.03% |
Man Group plc | 1,674,341 | $5,140,000 | 0.02% |
Baker Brothers Advisors | 935,000 | $2,870,000 | 0.02% |